Name: GDTC Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: GDTC, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does GDTC have?

Accepted Answer

CytoMed Therapeutics Ltd (GDTC) has 3 SEC Form 4 filings (5 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jul 25, 2026.

Question 2

When was the most recent SEC Form 4 filing for GDTC?

Accepted Answer

The most recent Form 4 filing for GDTC on Tracefour is dated Jul 25, 2026.

Question 3

Who is the most active insider at GDTC?

Accepted Answer

The most active SEC Form 4 filer at GDTC in the rolling window is Director, 10% Owner Choo Chee Kong, with 3 filings.

Question 4

What is the net insider flow at GDTC over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at GDTC have net bought $429K based on SEC Form 4 disclosures.

Question 5

What is the total insider buy and sell value at GDTC in the current window?

Accepted Answer

Inside the rolling window, insiders at GDTC bought $429K and sold $0 based on SEC Form 4 filings.

						Source
Choo Chee Kong	Director, 10% Owner	Purchase	100,000	$150K	Jul 25	SEC ↗
Choo Chee Kong	Director, 10% Owner	Purchase	100,000	$150K	Jul 25	SEC ↗
Choo Chee KongFirst filing	Director, 10% Owner	Purchase	112,000	$129K	Jun 15	SEC ↗

GDTC

Related companies